Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Patient Tailored Cancer Treatment Supported by Molecular Imaging IMPACT: IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer

NCT01957332 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT01957332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01957332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Patient Tailored Cancer Treatment Supported by Molecular Imaging IMPACT: IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 30, 2013
Completion date
October 31, 2027
Enrollment
217 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer